Convallamarin
Names | |
---|---|
Systematic IUPAC name
(1β,3β,5β,22R)-3-{[6-Deoxy-4-O-(β-D-glucopyranosyl)-β-D-gulopyranosyl]oxy}-26-(β-D-galactopyranosyloxy)-22-hydroxyfurost-25(27)-en-1-yl 6-deoxy-4-O-(6-deoxy-β-D-gulopyranosyl)-β-D-allopyranoside | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
ECHA InfoCard | 100.014.298 |
EC Number | 215-728-6 |
PubChem CID |
|
| |
| |
Properties | |
C57H94O27 | |
Molar mass | 1,211.35 g·mol−1 |
Appearance | Yellowish-white crystalline powder |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Convallamarin[1] is a crystalline glycoside extracted from Convallaria majalis.[2]
References
- ↑ "CONVALLAMARIN : MP Biomedicals". Retrieved 21 July 2010.
- ↑ "Materia Medica, General Therapeutics, and Pharmacy". The American Journal of the Medical Sciences. 57 (114): 527–528. April 1869.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.